Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-14-028653
Filing Date
2014-05-08
Accepted
2014-05-08 16:31:17
Documents
14
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v376666_10q.htm 10-Q 234160
2 EXHIBIT 10.1 v376666_ex10-1.htm EX-10.1 79731
3 EXHIBIT 10.2 v376666_ex10-2.htm EX-10.2 121749
4 EXHIBIT 10.3 v376666_ex10-3.htm EX-10.3 475055
5 EXHIBIT 31.1 v376666_ex31-1.htm EX-31.1 9800
6 EXHIBIT 31.2 v376666_ex31-2.htm EX-31.2 9691
7 EXHIBIT 32.1 v376666_ex32-1.htm EX-32.1 4421
8 EXHIBIT 32.2 v376666_ex32-2.htm EX-32.2 4180
  Complete submission text file 0001144204-14-028653.txt   2251743

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT plx-20140331.xml EX-101.INS 125407
10 XBRL TAXONOMY EXTENSION SCHEMA plx-20140331.xsd EX-101.SCH 19048
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE plx-20140331_cal.xml EX-101.CAL 31748
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE plx-20140331_def.xml EX-101.DEF 41806
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE plx-20140331_lab.xml EX-101.LAB 245586
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE plx-20140331_pre.xml EX-101.PRE 104354
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33357 | Film No.: 14825431
SIC: 2836 Biological Products, (No Diagnostic Substances)